Get started
JOHNSON DRNJOHNSON DRNJOHNSON DRN

JOHNSON DRN

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Seasonals Bonds

JNJB34 chart


Full chart

Key facts today


Barclays has revised Johnson & Johnson's price target to $166 from $159 while keeping an equal-weight rating.
Analyze the impactAnalyze the impact

Key stats


Market capitalization
‪2.10 T‬ BRL
Dividend yield (indicated)
2.34%
Price to earnings Ratio (TTM)
27,585.71
Basic EPS (TTM)
—
Net income (FY)
‪75.83 B‬ BRL
Revenue (FY)
‪478.83 B‬ BRL
Shares float
—
Beta (1Y)
−0.10

About Johnson & Johnson


Sector
Health Technology
CEO
Joaquin Duato
Headquarters
New Brunswick
Website
jnj.com
Founded
1887
ISIN
BRJNJBBDR002
FIGI
BBG0025NPG24
Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The MedTech segment includes a portfolio of products used in the interventional solutions, orthopaedics, surgery, and vision categories. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1887 and is headquartered in New Brunswick, NJ.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

JNJB34 news



Ideas



See all ideas 

Technicals

Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

JNJB34 highest yielding bonds


US478160CS1
JOHNSON&JOHN 20/50
Yield to maturity
6.88%
Maturity date
Sep 1, 2050
US478160CT9
JOHNSON&JOHN 20/60
Yield to maturity
6.85%
Maturity date
Sep 1, 2060
US478160CR3
JOHNSON&JOHN 20/40
Yield to maturity
6.50%
Maturity date
Sep 1, 2040
US478160CM4
JOHNSON & JOHNSON 17/48
Yield to maturity
6.10%
Maturity date
Jan 15, 2048
JNJJ
JOHNSON & JOHNSON 17/47
Yield to maturity
5.97%
Maturity date
Mar 3, 2047
US478160BV5
JOHNSON & JOHNSON 16/46
Yield to maturity
5.96%
Maturity date
Mar 1, 2046
US478160CL6
JOHNSON & JOHNSON 17/38
Yield to maturity
5.63%
Maturity date
Jan 15, 2038
US478160CF9
JOHNSON & JOHNSON 17/37
Yield to maturity
5.49%
Maturity date
Mar 3, 2037
US478160CX0
JOHNSON&JOHN 24/54
Yield to maturity
5.44%
Maturity date
Jun 1, 2054
JNJ4077469
Johnson & Johnson 4.5% 05-DEC-2043
Yield to maturity
5.43%
Maturity date
Dec 5, 2043
US478160BA1
JOHNSON & JOHNSON 11/41
Yield to maturity
5.41%
Maturity date
May 15, 2041

Explore more bonds 

Sparks


Curated watchlists where JNJB34 is featured.

See all sparks